Literature DB >> 6870963

Identification of a new metabolite of tamoxifen in patient serum during breast cancer therapy.

R R Bain, V C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6870963     DOI： 10.1016/0006-2952(83)90571-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.

Authors:  V Craig Jordan
Journal:  Ann Surg Oncol       Date:  2019-03-25       Impact factor: 5.344

Review 2.  New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors:  V Craig Jordan
Journal:  Steroids       Date:  2007-07-27       Impact factor: 2.668

3.  The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators.

Authors:  V Craig Jordan; Russell McDaniel; Fadeke Agboke; Philipp Y Maximov
Journal:  Steroids       Date:  2014-06-17       Impact factor: 2.668

4.  Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients.

Authors:  Y Tanaka; M Sekiguchi; T Sawamoto; T Hata; Y Esumi; S Sugai; S Ninomiya
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

Review 5.  The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.

Authors:  Philipp Y Maximov; Theresa M Lee; V Craig Jordan
Journal:  Curr Clin Pharmacol       Date:  2013-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.